Status: current, Defined. Date: 31-Jan 2023. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
5160708016 | Fidaxomicin 40 mg/mL oral suspension | en | Synonym | Active | Initial character case insensitive | SNOMED CT core |
5160709012 | Product containing precisely fidaxomicin 40 milligram/1 milliliter conventional release oral suspension (clinical drug) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Fidaxomicin 40 mg/mL oral suspension | Is a | Fidaxomicin only product in oral dose form | true | Inferred relationship | Some | ||
Fidaxomicin 40 mg/mL oral suspension | Plays role | Antibacterial therapeutic role | true | Inferred relationship | Some | ||
Fidaxomicin 40 mg/mL oral suspension | Has precise active ingredient | Fidaxomicin | true | Inferred relationship | Some | 1 | |
Fidaxomicin 40 mg/mL oral suspension | Has BoSS | Fidaxomicin | true | Inferred relationship | Some | 1 | |
Fidaxomicin 40 mg/mL oral suspension | Has concentration strength numerator unit | mg | true | Inferred relationship | Some | 1 | |
Fidaxomicin 40 mg/mL oral suspension | Has concentration strength denominator unit | mL | true | Inferred relationship | Some | 1 | |
Fidaxomicin 40 mg/mL oral suspension | Has manufactured dose form | Oral suspension | true | Inferred relationship | Some |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets